SS&C Signs Agreement with Insignia Financial
WINDSOR, Conn., Dec. 10, 2024 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced an initial agreement with Insignia Financial (Insignia) to deliver superannuation member administration services. Insignia Financial...
Firmable Hits 1500 Users, Gaining Momentum in the Australian Market
MELBOURNE, Australia, Dec. 10, 2024 /PRNewswire/ -- After just nine months in the market, Firmable is rapidly gaining traction as Australia's leading B2B sales and marketing database. This early success signals a shift in how Australian businesses...
Capture, Celebrate, and Save Big: Reolink's Holiday Deals and #reocap Fun!
LOS ANGELES, Dec. 10, 2024 /PRNewswire/ -- This holiday season, Reolink, an innovative leader in intelligent visual technology for the home, is extending warm wishes for a joyful and safe celebration. With heartfelt celebrations and meaningful...
Adoption of an Exclusive Human Milk Diet Reduces Malnutrition Rates Among Vulnerable Premature Infants in Sydney Hospital
Preliminary Data From Observational Study Presented at Australian and New Zealand Neonatal Network Clinical Practice Improvement Conference ADELAIDE, Australia, Dec. 10, 2024 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital...
Shawn "JAY-Z" Carter Files Motion Seeking Dismissal of Anonymous Lawsuit Or Disclosure of Plaintiff's Identity
NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Today, Shawn "JAY-Z" Carter filed a motion, seeking dismissal of the anonymous lawsuit submitted by attorney Tony Buzbee of the disclosure of the plaintiff's identity to remain anonymous. The filing from...
Abu Dhabi Finance Week 2024 Opens with Top Financial Leaders in the 'Capital of Capital'
ABU DHABI, UAE, Dec. 10, 2024 /PRNewswire/ -- Under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi and Chairman of the Executive Council, one of MENA's most anticipated four-day event...
Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial
Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Huntington's Disease Volumetric MRI measurement is also approved as exploratory study endpoint BOSTON,...
GoodWe Named Among 2024 Forbes China Go-International Series Top 30 Brands
DENVER, Dec. 10, 2024 /PRNewswire/ -- GoodWe, a global leader in solar inverter manufacturing and energy solutions, has been listed among the Top 30 Brands in the 2024 Forbes China Go-International Series, recognizing its excellence in...